Ernie Balcueva
Hematology & Oncology · Saginaw, MINPI 1154365252
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Amgen at 56.0% of the total. Reporting peaked in 2019 at $6,498 and has fallen 98.0% since, to $128 in 2022.
Across 153 payments — averaging $52.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$5K
- Genentech USA, Inc.$539
- AstraZeneca$356
- Pfizer$229
- Eisai Inc.$202
- E.r. Squibb & Sons, L.L.C.$177
- plus $2K from 38 others
What the payments were for
- Consulting fees$3,30041%
- Speaking & faculty fees$400%
- Travel & lodging$97212%
- Food & beverage$3,38542%
- Education$3705%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,066 in reported general payments places this provider in the 80th percentile of 282 hematology & oncology providers in Michigan.
Other hematology & oncology in Saginaw
- Bei LiuSaginaw$9K
- Faisal MusaDearborn$976K
- Mohammed Al HallakDetroit$644K
- Daniel LebovicGrosse Pointe Woods$352K
- Sreenivasa ChandanaGrand Rapids$305K
- Mohammad ChistiTroy$180K
- Gordon SrkalovicLansing$167K
- Jeffrey ZonderDetroit$88K
- Madan AroraFlint$84K
- Hadeel AssadDetroit$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.